Market Overview & Sector-wise take!

Equity markets corrected ~11% from recent peaks, creating selective value across banking, pharma, IT, and PSU sectors. Medium- to long-term outlook remains constructive amid improving macro fundamentals.

Our Sector wise Take

A sector-wise investment perspective during COVID-19, highlighting selective opportunities in banking, IT, pharma, and PSUs amid heightened volatility and valuation dislocations.

Pharma & Healthcare Sector to Outperform

Pharma and healthcare are positioned to outperform, supported by rising healthcare infrastructure spending, improving pharma valuations, and structural tailwinds across domestic formulations, APIs, and US generics.

Opportunities in Road Sector (India)

India’s road sector is undergoing a structural turnaround driven by policy reforms, improved execution models, and renewed private capital interest, offering attractive long-term investment opportunities across assets and listed equities.